Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov 10;21(1):219.
doi: 10.1186/s12881-020-01159-y.

Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report

Affiliations
Case Reports

Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report

Laura Schultz-Rogers et al. BMC Med Genet. .

Abstract

Background: Damaging variants in TRIO have been associated with moderate to severe neurodevelopmental disorders in humans. While recent work has delineated the positional effect of missense variation on the resulting phenotype, the clinical spectrum associated with loss-of-function variation has yet to be fully defined.

Case presentation: We report on two probands with novel loss-of-function variants in TRIO. Patient 1 presents with a severe neurodevelopmental disorder and macrocephaly. The TRIO variant is inherited from his affected mother. Patient 2 presents with moderate developmental delays, microcephaly, and cutis aplasia with a frameshift variant of unknown inheritance.

Conclusions: We describe two patients with neurodevelopmental disorder, macro/microcephaly, and cutis aplasia in one patient. Both patients have loss-of-function variants, helping to further characterize how these types of variants affect the phenotypic spectrum associated with TRIO. We also present the third reported case of autosomal dominant inheritance of a damaging variant in TRIO.

Keywords: Autism; Cutis aplasia; Macrocephaly; Microcephaly; TRIO gene.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Variants associated with neurodevelopment disorder in TRIO. Schematic of protein domains of human TRIO (NM_NM_007118.3). Variants discussed in this report are in black. Variants associated with microcephaly are in blue; microcephaly-associated frameshift/nonsense variants span the gene, while microcephaly-associated missense variants cluster in the GEF1 domain. Macrocephaly-associated missense variants cluster in the Spectrin repeats domain. With the exception of current patient 1 described here, all frameshift/nonsense variants have to date been associated with microcephaly
Fig. 2
Fig. 2
Characteristics of patients described with novel loss-of-function variants in TRIO. a Photograph of patient 1 displaying macrocephaly, broad forehead, deep set eyes, broad nasal root, hanging columella and short philtrum. b Pedigree for patient 1. c. Pedigree for patient 2

Similar articles

Cited by

References

    1. Schmidt S, Debant A. Function and regulation of the rho guanine nucleotide exchange factor trio. Small GTPases. 2014;5:e29769. doi: 10.4161/sgtp.29769. - DOI - PMC - PubMed
    1. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420(6916):629–635. doi: 10.1038/nature01148. - DOI - PubMed
    1. Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, Streuli M. The multidomain protein trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc Natl Acad Sci U S A. 1996;93(11):5466–5471. doi: 10.1073/pnas.93.11.5466. - DOI - PMC - PubMed
    1. Govek EE, Newey SE, Van Aelst L. The role of the rho GTPases in neuronal development. Genes Dev. 2005;19(1):1–49. doi: 10.1101/gad.1256405. - DOI - PubMed
    1. Cannet A, Schmidt S, Delaval B, Debant A. Identification of a mitotic Rac-GEF, trio, that counteracts MgcRacGAP function during cytokinesis. Mol Biol Cell. 2014;25(25):4063–4071. doi: 10.1091/mbc.e14-06-1153. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances